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A 23-year-old man was admitted to our hospital with a 12-day history of daily fever. A clinical history 
revealed that 10 months previously, the patient had been splenectomized and polytransfused for a severe 
blunt trauma. His general clinical conditions rapidly worsened into a severe systemic inflammatory 
response syndrome. After 10 days of broad-spectrum antibiotic treatment, the temperature curve was 
unmodified and severe leukocytosis persisted (44,300 ul) with absolute lymphocytosis. Laboratory tests 
ruled out hematological diseases, pneumonia, abscesses and endocarditis. In the light of IgM positivity 
for CMV (unconfirmed by PCR) and with the support of a PubMed search, we commenced a salvage 
treatment with intravenous ganciclovir, suspecting a viral infection or reactivation. After two days of 
therapy, an immediate defervescence was observed with a remarkable clinical improvement. After 
10 days, the clinical syndrome had been completely resolved and the patient was discharged in good, 
general clinical health.
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LETTER TO THE EDITOR
Case report
Prolonged fever is a medical challenge, especially 
when it is not responsive to empirical therapy and it 
rapidly evolves into a severe clinical picture, pending 
results from laboratory examinations (1). A 23-year-
old man, previously in good health, was admitted 
with a 12-day history of daily fever (T max 39.3°C), 
prevalently serotin, preceded by chills, associated with 
myalgias and a cough. The fever was not responsive 
to home antibiotic therapy with amoxicillin/
clavulanic acid nor subsequently with ceftriaxone 
plus ciprofloxacin. A clinical history revealed that 10 
months prior to this hospitalization, the patient had 
been splenectomized and polytransfused for a severe 
blunt trauma. He also reported fractures of the femur 
and patella which had undergone osteosynthesis. 
After the splenectomy, the patient had undergonet 
monthly antibiotic prophylaxis with diaminocillin 
for six months. 
On admission, the patient was febrile but his 
clinical conditions were not compromised. Blood 
pressure was 140/75 mmHg and heart rate 114 bpm. 
A physical examination revealed laterocervical 
lymphadenopathy and no pathologic signs on the 
skin, abdomen, lungs or heart. Laboratory data 
revealed: white blood cells 33,230/ul (4,000-
11,000/ul), neutrophils 42%, 13,820/ul (2,000-
8,000), lymphocytes 41%, 13,510/ul (1,000-5,000), 
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U/L); LDH 887 U/L(240-480 U/L); serum iron 
25 mg/dl (59-158 mg/dl); ferritin 393 ng/ml (30-
400 ng/ml), and a CRP 4.69 mg/dl (<0.5 mg/dl). 
A urinalysis was normal. A chest X-Ray excluded 
pneumonia, and abdominal ultrasounds showed 
hepatomegaly, various centimetric lymph nodes 
at the hepatic hilum and a small splenosis (2 cm) 
at the side of spleen. Considering this particular 
clinical picture, an empirical antibiotic treatment 
monocytes 11.2%, 3,730/ul (160-1,000), eosinophils 
4.2%, 1,410/ul (0-800), basophils 2.3%, 760/ul 
(<200), platelets 394,000/ul (150,000-450,000/ul); a 
hemoglobin level of 16.7 g/dl (12-18 g/dl); albumin 
3.5 g/dl (3.4-4.8 g/dl); INR 1.3 (0.8-1.2); bilirubin 
0.79 mg/dl (0.2-1.3 mg/dl); alanine aminotransferase 
129 U/L (<41 U/L); aspartate aminotransferase 59 
U/L (<37 U/L); gamma-glutamyltransferase 443 
U/L(<61 U/L); alkaline phosphatase 762 U/L(<129 
Clinical event Time Duration
Splenectomy and multiple trasfusions 10  months before hospitalization
Continous fever with Influenza-like symptoms 12 days before hospitalization 23 days
Significant leukocitosis , laboratory liver dysfunction On admission
General clinical worsening , onset of facial/limb edema
and coagulopaty
4 days after hospitalization
Positivity of serology for CMV, EBV and mycoplasma
pneumoniae
8 days after hospitalization
Ganciclovir treatment 10 days after hospitalization 10 days
Fever lysis with remarkable clinical improvement 2 days after Ganciclovir, 24 days after illness
manifestation
Thrombocytosis 4 days after Ganciclovir
Discharge 10 days after Ganciclovir treatment
Table I. Kinetic of patient’s history and clinical evolution of illness.
 
 
 
 
 
 
 
Table I. Kinetic of patient's history and clinical evolution of illness.
Fig. 1. Termic curve of patient and relation with treatment.
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<17; IgG 278 U/ml -v.n. <30) and Cytomegalovirus 
(IgM 11.9 U/ml - n.v. <1.1; IgG 14.6 U/ml -n.v. 
<1.1). CMV infection was not confirmed by CMV 
protein pp65 antigenemia and CMV DNA by PCR 
and, for this reason, a probable cross-reactivity was 
considered. A fundus oculi examination also ruled 
out retinitis. Complete autoanticorpal screening 
showed a positivity of ANA at 1:160 title with a 
granular pattern. 
After 10 days of hospitalization, the temperature 
curve was unmodified despite treatment and 
was poorly responsive to paracetamol (Fig. 
1). Leukocytosis persisted at very high levels 
(44,300 ul) with absolute lymphocytosis (19,700/
ul), monocytocis (7,100/ul) basophilia (800/ul), 
mild neutrophilia (10,400/ul) and the patient’s 
general conditions became extremely critical. 
Repeated pheripheral blood smears showed 8% of 
myeloid and lymphomonocyte precursors. Flow 
cytometry revealed 63% of lymphocytes (25,489 
on 40,460 of WBC) with a mild expansion of the 
T-lymphocyte population and an inversion of 
the CD4+/CD8+ ratio. Therefore, with a view to 
conducting an osteomedullary biopsy to exclude a 
lymphoproliferative disorder or hemophagocytic 
syndrome, all clinical data and history were carefully 
re-reviewed by the medical team. We considered 
as very significant the following clinical elements: 
splenectomy, fever, lymphocytosis and positivity for 
CMV, EBV and Mycoplasma pneumoniae. 
Thus, a search was conducted on PubMed 
using the following strings: i. splenectomy/fever/ 
lymphocytosis; ii. Splenectomy/fever/Epstein-Barr 
virus; iii. splenectomy/fever/cytomegalovirus; and 
iv. splenectomy/fever/Mycoplasma Pneumoniae. 
The only relevant result, obtained using both the 
first and third strings, was the following: “Severe 
cytomegalovirus infection in multiply transfused, 
splenectomized, trauma patients” (2). In light of this 
search, a result compatible with the clinical history 
(splenectomy, multiple blood transfusions, severe 
febrile illness), and considering the aggressiveness 
of the clinical picture, a salvage treatment with 
intravenous ganciclovir (5 mg/ kg every 12 h) was 
commenced whilst suspecting a viral infection or 
reactivation. After two days of therapy, an immediate 
defervescence was observed and the patient presented 
a remarkable clinical improvement (Fig. 1). 
with teicoplanin, cefotaxime and claritromicin was 
immediately commenced. The diagnostic procedures 
for fever started and the pheripheral blood smear 
performed whilst suspecting a lymphoproliferative 
process, revealed: neutrophils 49%, lymphocytes 
37%, monocytes 7%, eosinophils 2%, basophils 0% 
and 6% of large size lymphomonocytes with rare 
myeloid precursors. Beta2-microglobulin was 4.3 
mg/dl (0.8-2.2 mg/dl). 
After 5 days of hospitalization, a high and 
continuous fever persisted (Fig. 1) and the general 
clinical conditions rapidly worsened into a severe 
systemic inflammatory response syndrome 
(SIRS), which was complicated by facial and 
limb edema and associated with: proteinuria (388 
mg/24hrs, n.v.<140), hypocalcaemia (7.1 mg/
dl, n.v. 8.4-10.2), hypoproteinemia (5.2 mg/dl, 
n.v.6.6-8.7), hypertriglyceridemia (243 mg/dl, 
n.v. <200), hyponatremia (125 mEq/L, n.v.132-
147), hypoalbuminemia (2.2 mg/dl, n.v.3.4-4.8), 
hypofibrinogaenemia (112 mg/dl, n.v.150-450), low 
AT III (61%, n.v.80-120) and Pches reduction (3040 
U/L, n.v.5320-12920), mild PTT prolongation (39 
sec, n.v.24-36), and high levels of D-dimer (3059 ng/
ml, n.v.<280) with normal total bilirubin and platelet 
count. On the basis of this result, a substitutive 
treatment with Antitrombin III was commenced. 
Doppler echocardiography excluded endocarditis 
and total body CT with contrast showed no sources of 
infection or abdominal-thoracic limphoadenopathy. 
To exclude a bone infection, orthopantomography 
and X-rays of femur and knee were also carried out 
and a small focus of osteomyelitis of alveolar bone of 
teeth 37 and 38 was revealed. 
Considering the unsuccessful antibiotic therapy, 
treatment was therefore shifted to metronidazole, 
piperacillin/tazobactam, levofloxacin and daptomicin. 
Meanwhile, all the results of laboratory examinations 
had been received. Septifast test, repeated blood, 
urine, and sputum cultures as well as throat swab and 
Mantoux test were all negative. Serology for main 
viral and bacterial infections (including H1N1, HIV, 
hepatitis A, B, C, and D virus, Adenovirus, Herpes 
Simplex virus, Brucella, Rickettsia, Leishmania, 
Chlamydia, Salmonella and Toxoplasma gondii, 
QuantiFERON-TB) revealed only: IgM positivity 
for Epstein-Barr virus VCA and IgM/IgG positivity 
for Mycoplasma Pneumoniae (IgM 38.6 U/ml - n.v. 
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B-lymphocyte counts of splenectomized patients may 
be due to loss of the reservoir function of the spleen. 
A splenectomy induces a change in the lymphocyte 
recirculating pool due to the loss of an important 
anatomical site of migration. However, some authors 
have observed that the percentages of total T-cells 
(CD3), T-helper cells (CD4), and T-suppressor cells 
(CD8) are reduced in all splenectomized subjects, 
but the results are statistically significant only 
for CD4 cells (7). Conversely, peripheral CD8+ 
population showed an increase in splenectomized 
subjects since its percentage in the spleen is normally 
high. Consequently, the ratio of CD4/CD8 cells is 
significantly decreased in splenectomized subjects 
(8). 
The level of the total complement CH50 in 
splenectomized population is significantly less 
than in the control group (5). Other authors have 
demonstrated that levels of C3, C4, and C5 are similar 
in splenectomized population and controls (6). These 
data demonstrate persistent abnormalities in the 
immune function in adult asplenic trauma patients in 
the absence of underlying lymphoreticular disorders, 
therefore suggesting a possible explanation for an 
increased septic risk in this patient group. 
Considerable circumstantial data strongly 
suggest that the virus involved in primary infection 
and reactivation or reinfection after transfusion 
is that of CMV. The incidence of these infections 
appears related both to the number of donors and 
to the quantity of blood received by a patient. 
CMV infection following transfusion is most likely 
secondary to the reactivation of the latent virus 
either in donor white blood cells or host tissues. 
Most CMV infections acquired after transfusion 
are either asymptomatic or characterized by a self-
limited infectious mononucleosis syndrome. There 
are, however, specific groups of patients for whom a 
primary CMV infection after transfusion may cause 
significant morbidity and/or mortality. The patients 
at risk are seronegative and they include: pregnant 
women, premature infants, recipients of organ 
transplants from seronegative donors, and limited 
groups of severely immunosuppressed oncology 
patients. 
Seropositive individuals have latent CMV 
infection with viral DNA present in peripheral 
blood leucocytes. Calamy (11) reported that a CMV 
After 4 days, a new occurrence of significant 
thrombocytosis (max value 813,000/ul) was also 
registered. After 5 days of therapy, the patient 
reported subjective well-being and leukocytosis 
was considerably reduced (28,870 vs 44,300) with 
a normalization of the neutrophil cell count and a 
reduction in lymphocytosis. After 10 days, treatment 
with ganciclovir was discontinued, and the patient 
was discharged in a good, clinical general health. At 
1-month and 1-year clinical follow-up the patient 
was found to be well.
This unusual case illustrates the presentation 
of a viral infection in a splenectomized, 
immunocompetent patient as a high continuous fever 
with sustained leukocytosis and lymphocytosis; 
it  also describes its clinical evolution as a severe 
SIRS with liver dysfunction. Table I summarizes the 
kinetic and evolution of the illness. 
Commonly, severe viral infections manifest 
themselves in immunocompromized patients, such as 
HIV patients, transplant allograft recipients, patients 
taking immunosuppressive agents or those with 
hematological diseases (leukemia and lymphoma), 
and they are frequently due to CMV (3). This report 
confirms the possibility that the spleen has a role not 
only in preventing bacterial sepsis with encapsulated 
organisms but also in providings first line filtration 
and a defense against the virus (4). Consequently, 
splenectomy modifies the pattern of viral infection 
in immunocompetent subjects and increases its 
severity, also leading to a quite aggressive disease.
Some authors have described that patients 
splenectomized for trauma have significantly 
decreased levels of IgM while levels of IgA 
and IgG are significantly increased (5). IgM 
synthesis by peripheral blood mononuclear 
cells in splenectomized patients was markedly 
diminished in vitro but IgG synthesis was normal. 
The splenectomized population has shown a total 
lymphocyte count with a significantly greater number 
of T cells and B lymphocytes than in the control 
group. Characterizing the mechanism responsible 
for the altered immune response in splenectomized 
patients, in vitro experiments have revealed an 
impaired T-helper cell capacity in addition to an 
intrinsic B-cell defect. The proliferative responses of 
lymphocytes to phytohemagglutinin is diminished in 
splenectomized patients (6). The significantly higher 
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clinician, recognizing these features may aid timely 
diagnosis. 
To conclude, this report suggests that the clinical 
history and timing are important features which may 
lead to the correct diagnosis and effective treatment 
also when the illness is aggressive and that laboratory 
results are not conclusive. Finally, PubMed is a very 
useful tool with which to confront an uncommon 
clinical picture. 
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